These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 2245435

  • 21. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT, Nieuwenhuijzen Kruseman AC, Degenaar CP, Wolffenbuttel BH.
    Ned Tijdschr Geneeskd; 1990 Nov 03; 134(44):2142-6. PubMed ID: 2247172
    [Abstract] [Full Text] [Related]

  • 22. [Mid-term clinical study of the effectiveness of and tolerability to simvastatin ++ in dyslipidemic patients].
    Irace L, Aiello C, Papa A, Sannino A, Petraglia L, De Lucia R, Dragonetti C.
    Minerva Med; 1992 Dec 03; 83(12):815-8. PubMed ID: 1491761
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 03; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 24. [Use and effect of simvastin in patients with type II diabetes].
    Camarda G.
    Clin Ter; 1993 Aug 03; 143(2):105-7. PubMed ID: 8222540
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 03; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 26. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J.
    Rev Med Univ Navarra; 1992 Jun 03; 37(3):127-33. PubMed ID: 1480917
    [Abstract] [Full Text] [Related]

  • 27. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J.
    Arq Bras Cardiol; 1990 Jun 03; 54(6):407-14. PubMed ID: 2288531
    [Abstract] [Full Text] [Related]

  • 28. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR.
    Minerva Med; 1992 Jun 03; 83(6):347-53. PubMed ID: 1630695
    [Abstract] [Full Text] [Related]

  • 29. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A, Brisighella Heart Study Working Party.
    Am Heart J; 2004 Aug 03; 148(2):285-92. PubMed ID: 15308998
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Aug 03; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 32. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 33. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

  • 34. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS, Vitaliano E, Rossi FG, Serra T, Santini G, Bernardi G.
    Clin Ter; 1991 Jan 15; 136(1):31-8. PubMed ID: 1826871
    [Abstract] [Full Text] [Related]

  • 35. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C.
    Clin Ter; 1994 Jan 15; 144(1):3-9. PubMed ID: 8168349
    [Abstract] [Full Text] [Related]

  • 36. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
    Pipicelli G, Pentimone F, Frustaci G, Notarangelo R, Beghè F.
    Minerva Med; 1992 Dec 15; 83(12):819-25. PubMed ID: 1491762
    [Abstract] [Full Text] [Related]

  • 37. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T, Gavelli MS, Vitaliano E, Santini G, Catalano A, Rossi FG, Tozzi J, Caridis R, Guarini G.
    Clin Ter; 1990 Mar 15; 132(5):307-13. PubMed ID: 2139833
    [Abstract] [Full Text] [Related]

  • 38. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Mar 15; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 39. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 40. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 27; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.